Page last updated: 2024-12-08

sedoheptulose 1,7-bisphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID164735
CHEBI ID17969
SCHEMBL ID19025189
MeSH IDM0077711

Synonyms (16)

Synonym
CHEBI:17969
d-altro-hept-2-ulose 1,7-bis(dihydrogen phosphate)
altro-heptulose 1,7-biphosphate
815-91-8
d-altro-heptulose 1,7-biphosphate
C00447
d-sedoheptulose 1,7-bisphosphate
sedoheptulose 1,7-bisphosphate
[(2r,3r,4r,5s)-2,3,4,5-tetrahydroxy-6-oxo-7-phosphonooxyheptyl] dihydrogen phosphate
altro heptulose 1,7-bisphosphate
d-altro-2-heptulose, 1,7-bis(dihydrogen phosphate)
SCHEMBL19025189
sedoheptulose-1,7-bisphosphate
(2r,3r,4r,5s)-2,3,4,5-tetrahydroxy-6-oxoheptane-1,7-diyl bis(dihydrogen phosphate)
Q27102740
DTXSID101002018
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
ketoheptose phosphate
sedoheptulose derivativeA ketoheptose derivative that is formally obtained from sedoheptulose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
Sedoheptulose Bisphosphate Bypass36
Riboneogenesis511
Photosynthesis6324
Calvin-Benson Cycle1321
Carbon assimilation C4 pathway030
Primary carbon metabolism2330
Calvin cycle1013

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (25.00)18.7374
1990's6 (30.00)18.2507
2000's5 (25.00)29.6817
2010's3 (15.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.68 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]